Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

Recruiting now · Not applicable

Conditions studied: Pancreatic Neuroendocrine Tumors, WHO Grade I-II

In brief

A national multicenter prospective study to investigate the feasibility and efficacy of endoscopic ultrasound guided radiofrequency ablation of neuroendocrine pancreatic tumors, WHO Grade 1-2 of 3 cm or less in diameter.

Key facts

Study ID
NCT05243082
Run by
Oslo University Hospital
People needed
20
Starts
2022-01-14
Expected to finish
2029-11-11
Last updated by the study team
2023-03-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.